Publication | Open Access

Nasal priming with immunobiotic Lactobacillus rhamnosus modulates inflammation–coagulation interactions and reduces influenza virus-associated pulmonary damage

Lung InflammationRespiratory DiseasesInflammation–coagulation InteractionsViral ImmunityImmunologyRespiratory InfectionInfectious Respiratory DiseaseInfluenza VaccineInfection ControlVirus-associated Pulmonary DamageMedicineClinical MicrobiologyImmunobiotic Lactobacillus Rhamnosus